bevacizumab,olaparib
astrazeneca,merck,roche
['gyn', 'bevacizumab', 'ovarian', ' bev ', 'lba29', 'paola-1', 'olaparib']
#esmo22 lba29 gyn malignancies. final os analysis of paola-1/engot-ov25: maintenance olaparib + bevacizumab vs pbo + bev in nd advanced ovarian cancer #ovariancancer #parpinhibitor 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge